Doblinger J

ORCID: 0000-0003-3534-4244 · 1 paper in corpus
2016
PloS one ·doi:10.1371/journal.pone.0151388

ObjectiveTo summarize efficacy and safety data on a new progesterone compound which is available for subcutaneous administration as compared to vaginally administered progesterone for luteal phase support in patients undergoing IVF treatmen…